Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
2002 1
2011 3
2012 1
2013 2
2014 1
2015 1
2017 2
2018 6
2019 4
2020 6
2021 5
2022 1
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Cruchaga C, Goate AA, Perrin RJ, Xiong C, Li Y, Morris JC, Snider BJ, Mummery C, Surti GM, Hannequin D, Wallon D, Berman SB, Lah JJ, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sánchez-Valle R, Brooks WS, Gauthier S, Galasko DR, Masters CL, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Jack CR Jr, Koeppe R, Snyder PJ, Aisen PS, Thomas RG, Berry SM, Wendelberger BA, Andersen SW, Holdridge KC, Mintun MA, Yaari R, Sims JR, Baudler M, Delmar P, Doody RS, Fontoura P, Giacobino C, Kerchner GA, Bateman RJ; Dominantly Inherited Alzheimer Network–Trials Unit. Salloway S, et al. Among authors: brosch jr. Nat Med. 2021 Jul;27(7):1187-1196. doi: 10.1038/s41591-021-01369-8. Epub 2021 Jun 21. Nat Med. 2021. PMID: 34155411 Free PMC article. Clinical Trial.
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.
Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, Xiong C, Pontecorvo MJ, Klein G, Su Y, Klunk WE, Jack C, Koeppe R, Snider BJ, Berman SB, Roberson ED, Brosch J, Surti G, Jiménez-Velázquez IZ, Galasko D, Honig LS, Brooks WS, Clarnette R, Wallon D, Dubois B, Pariente J, Pasquier F, Sanchez-Valle R, Shcherbinin S, Higgins I, Tunali I, Masters CL, van Dyck CH, Masellis M, Hsiung R, Gauthier S, Salloway S, Clifford DB, Mills S, Supnet-Bell C, McDade E, Bateman RJ, Benzinger TLS; DIAN-TU Study Team. Chen CD, et al. Among authors: brosch j. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5. Eur J Nucl Med Mol Imaging. 2023. PMID: 37017737 Free PMC article. Clinical Trial.
Immunotherapy for Alzheimer's disease.
Farlow MR, Brosch JR. Farlow MR, et al. Among authors: brosch jr. Neurol Clin. 2013 Aug;31(3):869-78. doi: 10.1016/j.ncl.2013.03.012. Epub 2013 May 18. Neurol Clin. 2013. PMID: 23896510 Review.
Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
Swinford CG, Risacher SL, Vosmeier A, Deardorff R, Chumin EJ, Dzemidzic M, Wu YC, Gao S, McDonald BC, Yoder KK, Unverzagt FW, Wang S, Farlow MR, Brosch JR, Clark DG, Apostolova LG, Sims J, Wang DJ, Saykin AJ. Swinford CG, et al. Among authors: brosch jr. Neurobiol Aging. 2023 Oct;130:103-113. doi: 10.1016/j.neurobiolaging.2023.06.014. Epub 2023 Jun 28. Neurobiol Aging. 2023. PMID: 37499587
Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease.
Yu M, Risacher SL, Nho KT, Wen Q, Oblak AL, Unverzagt FW, Apostolova LG, Farlow MR, Brosch JR, Clark DG, Wang S, Deardorff R, Wu YC, Gao S, Sporns O, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Yu M, et al. Among authors: brosch jr. Cell Rep. 2024 Feb 27;43(2):113691. doi: 10.1016/j.celrep.2024.113691. Epub 2024 Jan 19. Cell Rep. 2024. PMID: 38244198 Free PMC article.
Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT.
Gosewisch A, Schleske M, Gildehaus FJ, Berg I, Kaiser L, Brosch J, Bartenstein P, Todica A, Ilhan H, Böning G. Gosewisch A, et al. Among authors: brosch j. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1260-1261. doi: 10.1007/s00259-020-05024-1. Epub 2020 Sep 21. Eur J Nucl Med Mol Imaging. 2021. PMID: 32959113 Free PMC article. No abstract available.
BrainAGE Estimation: Influence of Field Strength, Voxel Size, Race, and Ethnicity.
Dempsey DA, Deardorff R, Wu YC, Yu M, Apostolova LG, Brosch J, Clark DG, Farlow MR, Gao S, Wang S, Saykin AJ, Risacher SL; Alzheimer’s Disease Neuroimaging Initiative. Dempsey DA, et al. Among authors: brosch j. medRxiv [Preprint]. 2023 Dec 5:2023.12.05.23299222. doi: 10.1101/2023.12.05.23299222. medRxiv. 2023. PMID: 38106123 Free PMC article. Preprint.
38 results